drugset

drugset / Trial / NCT00366080

Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy

NCT00366080 ↗

Phase 2 Terminated 69 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the effectiveness and safety of the drug GSK189254 in treating patients with narcolepsy.

Timeline

Start: 2006-11
Primary completion: 2008-01
Completion: 2008-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GSK189254	Small molecule	—	—

Indications